Amicus Therapeutics, Inc. To Present At 32nd Annual J.P. Morgan Healthcare Conference

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CRANBURY, N.J., Jan. 10, 2014 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a biopharmaceutical company at the forefront of developing therapies for rare and orphan diseases, today announced that John F. Crowley, Chairman and Chief Executive Officer, will present the Company’s full-year 2014 strategic outlook at the 32nd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2014 at 11:30 a.m. PT (2:30 p.m. ET).

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC